Shanghai Yuli Chemical Technology Co., Ltd. was established in 2008. The company is primarily engaged in the development, research, and industrial production of chiral compounds, pharmaceutical intermediates, special amino acids, and UV-curable cationic iodonium salts. Main products include: hypervalent organic iodine compounds (such as iodobenzene diacetate, bis(trifluoroacetoxy)iodobenzene), 4-((2-hydroxytetradecyl)phenyl)iodonium hexafluoroantimonate, diphenylmethylene glycinate series, alpha-cyclic amino acids (1-aminocyclopropanecarboxylic acid, cycloleucine), anserine, ectoin, homoserine and its lactone derivatives, 3-amino-3-arylpropanoic acid series, amino aldehydes, and other special amino acids and derivatives, chiral intermediates, guanidine compounds, substituted mandelic acid series, and novel pharmaceutical intermediates. The production site is located in the Jinshan Fine Chemical Park in Shanghai, capable of providing ton-scale, hundred-kilogram-scale, and kilogram-scale production. The company obtained ISO9001 quality system certification in 2010 and can offer analyses such as NMR, MS, IR, UV, HPLC, and GC to ensure the high quality of its products.     "Scientific management, dedication to practicality, customer first, and striving for progress" are the consistent principles upheld by Yuli Chemical. Meeting customer requirements and expectations is the foundation for the company's continuous development. "Management innovation, technological advancement, and quality excellence" are the guiding policies for the company's growth. Yuli Chemical aims to promote the common health of humanity and society and to achieve mutual development for both the enterprise and the nation.